The disclosure relates generally to methods and arrangements relating to medical devices. More specifically, the disclosure relates to systems and methods used in medical device patient contact interfaces especially used in external defibrillators or wearable cardioverter defibrillators.
A primary task of the heart is to pump oxygenated, nutrient-rich blood throughout the body. Electrical impulses generated by a portion of the heart regulate the pumping cycle. When the electrical impulses follow a regular and consistent pattern, the heart functions normally and the pumping of blood is optimized. When the electrical impulses of the heart are disrupted (i.e., cardiac arrhythmia), this pattern of electrical impulses becomes chaotic or overly rapid, and a Sudden Cardiac Arrest may take place, which inhibits the circulation of blood. As a result, the brain and other critical organs are deprived of nutrients and oxygen. A person experiencing Sudden Cardiac Arrest may suddenly lose consciousness and die shortly thereafter if left untreated.
The most successful therapy for Sudden Cardiac Arrest is prompt and appropriate defibrillation. A defibrillator uses electrical shocks to restore the proper functioning of the heart. A crucial component of the success or failure of defibrillation, however, is time. Ideally, a victim should be defibrillated immediately upon suffering a Sudden Cardiac Arrest, as the victim's chances of survival dwindle rapidly for every minute without treatment.
There are a wide variety of defibrillators. For example, Implantable Cardioverter-Defibrillators (ICD) involve surgically implanting wire coils and a generator device within a person. ICDs are typically for people at high risk for a cardiac arrhythmia. When a cardiac arrhythmia is detected, a current is automatically passed through the heart of the user with little or no intervention by a third party.
Another, more common type of defibrillator is the automated external defibrillator (AED). Rather than being implanted, the AED is an external device used by a third party to resuscitate a person who has suffered from sudden cardiac arrest.
A typical protocol for using the AED 800 is as follows. Initially, the person who has suffered from sudden cardiac arrest is placed on the floor. Clothing is removed to reveal the person's chest 808. The pads 804 are applied to appropriate locations on the chest 808, as illustrated in
Although existing technologies work well, there are continuing efforts to improve the effectiveness, safety and usability of automatic external defibrillators.
Accordingly, efforts have been made to improve the availability of automated external defibrillators (AED), so that they are more likely to be in the vicinity of sudden cardiac arrest victims. Advances in medical technology have reduced the cost and size of automated external defibrillators (AED). Some modern AEDs approximate the size of a laptop computer or backpack. Even small devices may typically weigh 4-10 pounds or more. Accordingly, they are increasingly found mounted in public facilities (e.g., airports, schools, gyms, etc.) and, more rarely, residences. Unfortunately, the average success rates for cardiac resuscitation remain abysmally low (less than 1%).
Such solutions, while effective, are still less than ideal for most situations. Assume, for example, that a person suffers from a cardiac arrest in an airport in which multiple AEDs have been distributed. The victim's companion would nevertheless have to locate and run towards the nearest AED, pull the device off the wall, and return to the collapsed victim to render assistance. During that time, precious minutes may have passed. According to some estimates, the chance of surviving a sudden cardiac arrest is 90% if the victim is defibrillated within one minute, but declines by 10% for every minute thereafter. A defibrillator design that reduces the time to defibrillation by even two to three minutes will save more lives.
An additional challenge is that a sudden cardiac arrest may take place anywhere. People often spend time away from public facilities and their homes. For example, a sudden cardiac arrest could strike someone while biking in the hills, skiing on the mountains, strolling along the beach, or jogging on a dirt trail. Ideally, an improved AED design would be compact, light, and resistant to the elements and easily attached or detached from one's body. The typical AED design illustrated in
New and improved designs are allowing AEDs to become ultra-portable and hence to able to be easily carried by an at-risk person as they go about all of their daily activities and thus are able to be close at hand when a sudden cardiac arrest strikes outside of a hospital environment or a high traffic public area with a Public Access Defibrillator.
There are also improvements being made in the area of device usability and ease of operation for untrained bystanders. As noted above, every minute of delay or distraction can substantially decrease the victim's probability of survival. As a result, it is generally beneficial to streamline the operation of the external defibrillator so that a user of the defibrillator, who is presumably under substantial mental duress, can focus his or her attention on a few key variables.
Another type of defibrillator is the Wearable Cardioverter Defibrillator (WCD). Rather than a device being implanted into a person at-risk from Sudden Cardiac Arrest, or being used by a bystander once a person has already collapsed from experiencing a Sudden Cardiac Arrest, the WCD is an external device worn by an at-risk person which continuously monitors their heart rhythm to identify the occurrence of an arrhythmia, to then correctly identify the type of arrhythmia involved and then to automatically apply the therapeutic action required for the type of arrhythmia identified, whether this be cardioversion or defibrillation. These devices are most frequently used for patients who have been identified as potentially requiring an ICD and to effectively protect them during the two to six month medical evaluation period before a final decision is made and they are officially cleared for, or denied, an ICD.
External Defibrillators and Automated External Defibrillators on the market today make use of either rigid paddles that must be held in place on the patient's body or else flexible electrode pads (made of conductive foil and foam) which are stuck to the patient's skin. The current external defibrillators that have rigid paddle bases do not conform to the curvatures of the patient's body at the locations on the body where the paddles must be placed in order to be effective. As such the operators of these devices must apply a good amount of contact force to make physical contact across the paddle's patient contact interface and must maintain this force to maximize the surface area in contact with the patient for the sensing and reading of the heart rhythm in order that the device can detect the presence of a faulty rhythm, or arrhythmia, such as Ventricular Fibrillation or Ventricular Tachycardia so as to instruct/initiate or signal the external defibrillator to deliver the life saving therapeutic defibrillation shock pulse. The operator must also continue holding the required contact force while the device delivers the chosen therapeutic action (shock or no shock).
There are medical, practical and commercial needs to make new AEDs which are smaller, potentially even flexible, and hence much more discrete in order for patients to be able to carry the devices around with them as they go about their daily lives. This means that the life saving device is always with them for a bystander to use immediately if they drop from a Sudden Cardiac Arrest. This is far preferable to the current system of having a few AEDs mounted on the walls of a limited number of the most high traffic public locations.
Wearable Cardioverter Defibrillators on the market today are still bulky and uncomfortable for the patients to wear. They utilize a single source of energy in a box that attaches to the wearable garment (containing the sensors and the electrodes) and the energy source box normally rides on the hip. These are heavy and uncomfortable to wear and a frequent source of complaints from patients.
Current Wearable Cardioverter Defibrillators have fixed flat surface electrodes and fixed curved surface electrodes for positioning on the patient's back and abdomen. This requires that each patient has to be specially fitted for their own unit, which is time consuming for the patient. Given the limited range of device sizes available it also requires that the device be worn tightly in order to maintain a constant contact pressure with both the sensors and the electrodes, which is restrictive and can be uncomfortable for the patient. This is also the reason why the devices also employ the use of liquid conductive hydrogel, to ensure that the electrode-to-patient contact impedance is minimized. This is messy to clean up after each use when deployed by the device, and naturally this can adversely impact the patient's clothing. It also requires that the liquid reservoirs be recharged before the device can be effectively used again.
There are medical, practical and commercial needs to make new WCDs smaller and more flexible, more comfortable and more discrete for patients to wear as they go about their daily lives.
The disclosure is particularly applicable to a pliable patient contact interface that may be used with a wearable AED and it is in this context that the disclosure will be described. It will be appreciated, however, that the patient contact interface has greater utility since it may be used with any medical device or other system in which it is desirable to be able to conform a patient contact interface to a non-flat surface.
A way to improve AEDs and wearable AEDs is to make it so that the circuitry and the energy source/reservoir may be re-distributed from the one large container/enclosure found in existing AEDs into two or more smaller containers. Each of these smaller containers has their own circuitry and energy source/reservoir and they are also combined with the ECG sensors and a defibrillation shock electrode. The two smaller containers are then connected to each other electrically and packaged together for easy transportation. In the wearable AED system, the two or more smaller containers may be mounted on the body of the patient. The smaller and more effective that the sensors and the electrodes can be made the better, which means ensuring that they maximize the surface area in contact with the patient's skin and also maximize the quality of the contact with the patient's skin. The system thus allows AEDs and WCDs to be made smaller, potentially flexible, more comfortable and much more discrete.
The patient contact interface disclosed assists with an optimal contact being maintained with the patient and hence that the device-to-patient impedance is minimized without requiring that the patient be either fastened into a garment as tight fitting as a corset before being able to reliably sense a continuous ECG, or be dowsed in liquid conductive hydrogel before being administered a therapeutic shock.
The patient contact interface may employ a mix of sensor types, such as ECG sensors and LED optical pulse detectors, rather than the traditional use of just ECG sensors. This mix means that the AED's or WCD's accuracy of the detection of shockable arrhythmias can be significantly improved and hence the incidence of unnecessary shocks can be significantly reduced and hence in addition the need for a patient to use any shock override button is reduced. The mix of sensor types may further include sensors which can be active in nature, passive in nature, or a combination of the two types. A passive sensor may be a sensor, like an ECG sensor, that just passively picks up a reading or signal, without taking any action itself. An active sensor may be a sensor, like a Pulse Oximeter, that actively performs a function such as shining a light into the patient's flesh in order to detect and analyze the reflected light from the blood flow in the patient's nearby blood vessels and hence identify the levels of oxygenation of that blood.
One embodiment of the patient contact interface allows external defibrillators with rigid paddles to provide a greater contact surface area with the patient's body, and an improved consistency of physical contact between the patient contacts and the patient's skin through using the natural tendency of the skin to give and conform to the shape of an object pressing into it without the need for the operator to apply excessive contact force. The use of the multi-part non-uniform patient contact interface ensures that there are multiple different contact points, each of which take advantage of the skin's natural tendency to give and conform, which ensures that a single contact location attaining a poor level of contact does not prevent the collection of the needed sensor readings nor the delivery of necessary therapy.
The patient contact interface can also be embodied to work with a wearable AED, or a Wearable Cardioverter Defibrillator, and this can be mounted on the patient in a number of different ways and in a number of different locations. The invention provides a more consistent contact surface area with the patient's body through the use of the multi-part non-uniform patient contact interface approach.
Through the utilization of a pliable yet stable substrate into which the multi-part non-uniform patient contact interface is embedded the invention can be flexed, wrapped and secured around almost any contours found at the relevant locations on a patient's body whilst maintaining a gentle pressure which ensures that a high quality level of device-to-patient contact is maintained. This improved consistency of physical contact between the patient contacts and the patient's skin is aided by the natural tendency of the skin to give and conform to the shape of any object pressing into it without the need for the operator to apply excessive contact force.
The arrangement of the patient contact elements may be varied and may include a single contact element, an array of contact elements, a portion of the assembly with bar contact elements and a portion of the assembly with button contact elements as shown in
The patient interface assembly described in this document may be placed onto a body of a patient and may be used, for example, to sense the heartbeat of the patient and then deliver a therapeutic pulse to the patient for defibrillation for example. The patient interface assembly may also be used to deliver other types of treatments of varying during to the patient. The patient interface assembly may also be used to sense a characteristic of the patient, such as a heartbeat or pulse and the like. The patient interface assembly may also be used to both sense a characteristic of the patient and deliver a treatment to the patient when the patient interface assembly has both sensors and electrodes.
The patient contact assembly may be placed onto the body of the patient at various locations, such as the torso, limbs and/or head of the patient. In some implementations, multiple patient contact assemblies may be used and each patient contact assembly may be placed on one or more locations on the body of the patient. In some embodiments, the patient contact assembly may have one or more patient contacts 101, 102 as shown in
The assembly (100) may have a substrate (103) to which the contact elements are attached. In one embodiment, a material of the substrate (103) in between the bars (101) and buttons (102) may be conductive (where the patient contact elements are conductive) and another embodiment where this material is not conductive (where the patient contact elements are conductive.) In another embodiment, the material of the substrate (103) may be constructed of the same material used for the bars (101) and buttons (102) and is formed from the same single piece of this material. In a different embodiment, the substrate (103) may be constructed of the same material but it is yet formed from separate pieces of this material.
While the patient contact elements may be constructed from conductive material, such as stainless steel, the range of embodiments allow for the inclusion of multiple types of sensor elements such as optical sensors, electrical sensors, temperature sensors or even complex micro circuits or micro-mechanical circuits which may be used to fulfill a variety of functions and which may not be constructed from a conductive material. In the multi-part non-uniform patient contact interface assembly (100) a single type of sensor, or electrode, or multiple different types of sensors, or electrodes, can be incorporated individually, or in separated groups, and partially or fully intermixed within the same multi-part non-uniform patient contact interface assembly (100). The sensor elements, along with a similarly wide variety of potential electrode elements, can be implemented individually or as part of one large extended array, or as multiple smaller arrays, or in any combination of these approaches.
The described Multi-part Non-uniform Patient Contact Interface allows for ideal Patient body contact without the need for the device operator to directly apply sustained contact force. An adhesive on the edge of the Defibrillator paddle may hold the assembly in place while the flexibility of the Multi-part Non-uniform Patient Contact Interface contacts the Patient body. The patient contact assembly may reduce the need for the operator to be in contact with the Defibrillator or Patient, removing the risk to the operator and reducing the risk to the patient.
The patient contact interface may allow for the weight of the rigid device that it is part of to be reduced or the flexibility of the pliable substrates that it is built with to be maintained along with its method of attachment to the patient. The patient contact interface sustains the high quality contact between the patient contact elements and the patient's skin, despite the movements of the operator or of the patient.
While the foregoing has been with reference to a particular embodiment of the invention, it will be appreciated by those skilled in the art that changes in this embodiment may be made without departing from the principles and spirit of the disclosure, the scope of which is defined by the appended claims.
This application claims the benefit under 35 USC 119(e) and 120 to U.S. Provisional Patent Application No. 61/835,465 filed on Jun. 14, 2013 and entitled “Multipart Non-Uniform Sensor Contact Interface and Method of Use” and to U.S. Provisional Patent Application No. 61/835,478 filed on Jun. 14, 2013 and entitled “Multipart Non-Uniform Electrode Contact Interface and Method of Use”, the entirety of both of which are incorporated herein by reference.
Number | Name | Date | Kind |
---|---|---|---|
4441498 | Nordling | Apr 1984 | A |
5199429 | Kroll et al. | Apr 1993 | A |
5240995 | Gyory | Aug 1993 | A |
5290585 | Elton | Mar 1994 | A |
5338490 | Dietz | Aug 1994 | A |
5362420 | Itoh | Nov 1994 | A |
5402884 | Gilman et al. | Apr 1995 | A |
5489624 | Kantner | Feb 1996 | A |
5536768 | Kantner | Jul 1996 | A |
5573668 | Grosh | Nov 1996 | A |
5643252 | Waner et al. | Jul 1997 | A |
5658316 | Lamond et al. | Aug 1997 | A |
5660178 | Kantner | Aug 1997 | A |
5733310 | Lopin et al. | Mar 1998 | A |
5800685 | Perrault | Sep 1998 | A |
5871505 | Adams | Feb 1999 | A |
5987354 | Cooper | Nov 1999 | A |
6004312 | Finneran et al. | Dec 1999 | A |
6006131 | Cooper et al. | Dec 1999 | A |
6056738 | Marchitto et al. | May 2000 | A |
6141584 | Rockwell et al. | Oct 2000 | A |
6197324 | Crittenden | Mar 2001 | B1 |
6251100 | Flock et al. | Jun 2001 | B1 |
6256533 | Yuzhakov et al. | Jul 2001 | B1 |
6266563 | Kenknight et al. | Jul 2001 | B1 |
6315722 | Yaegashi | Nov 2001 | B1 |
6329488 | Terry | Dec 2001 | B1 |
6379324 | Gartstein et al. | Apr 2002 | B1 |
6477413 | Sullivan et al. | Nov 2002 | B1 |
6576712 | Feldstein | Jun 2003 | B2 |
6596401 | Terry | Jul 2003 | B1 |
6597948 | Rockwell et al. | Jul 2003 | B1 |
6611707 | Prausnitz | Aug 2003 | B1 |
6690959 | Thompson | Feb 2004 | B2 |
6714817 | Daynes et al. | Mar 2004 | B2 |
6797276 | Glenn | Sep 2004 | B1 |
6803420 | Cleary | Oct 2004 | B2 |
6908453 | Fleming | Jun 2005 | B2 |
6908681 | Terry | Jun 2005 | B2 |
6931277 | Yuzhakov | Aug 2005 | B1 |
7072712 | Kroll et al. | Jul 2006 | B2 |
7108681 | Gartstein | Sep 2006 | B2 |
7215991 | Besson et al. | May 2007 | B2 |
7226439 | Prausnitz | Jun 2007 | B2 |
7463917 | Martinez | Dec 2008 | B2 |
7645263 | Angel et al. | Jan 2010 | B2 |
7797044 | Covey et al. | Sep 2010 | B2 |
8024037 | Kumar | Sep 2011 | B2 |
8527044 | Edwards et al. | Sep 2013 | B2 |
8558499 | Ozaki et al. | Oct 2013 | B2 |
8615295 | Savage et al. | Dec 2013 | B2 |
8781576 | Savage et al. | Jul 2014 | B2 |
9089718 | Owen et al. | Jul 2015 | B2 |
9101778 | Savage et al. | Aug 2015 | B2 |
9616243 | Raymond et al. | Apr 2017 | B2 |
9656094 | Raymond et al. | May 2017 | B2 |
20010031992 | Fishler et al. | Oct 2001 | A1 |
20020016562 | Cormier et al. | Feb 2002 | A1 |
20020045907 | Sherman et al. | Apr 2002 | A1 |
20020082644 | Picardo et al. | Jun 2002 | A1 |
20030017743 | Picardo et al. | Jan 2003 | A1 |
20030055460 | Owen et al. | Mar 2003 | A1 |
20030088279 | Rissmann et al. | May 2003 | A1 |
20030125771 | Garrett et al. | Jul 2003 | A1 |
20030167075 | Fincke | Sep 2003 | A1 |
20030197487 | Tamura et al. | Oct 2003 | A1 |
20040105834 | Singh | Jun 2004 | A1 |
20040143297 | Ramsey, III | Jul 2004 | A1 |
20040166147 | Lundy | Aug 2004 | A1 |
20040247655 | Asmus | Dec 2004 | A1 |
20050055460 | Johnson et al. | Mar 2005 | A1 |
20050107713 | Van Herk | May 2005 | A1 |
20050123565 | Subramony | Jun 2005 | A1 |
20060136000 | Bowers | Jun 2006 | A1 |
20060142806 | Katzman et al. | Jun 2006 | A1 |
20060173493 | Armstrong et al. | Aug 2006 | A1 |
20060206152 | Covey et al. | Sep 2006 | A1 |
20070016268 | Carter et al. | Jan 2007 | A1 |
20070078376 | Smith | Apr 2007 | A1 |
20070135729 | Ollmar et al. | Jun 2007 | A1 |
20070143297 | Recio et al. | Jun 2007 | A1 |
20070150008 | Jones et al. | Jun 2007 | A1 |
20070191901 | Schecter | Aug 2007 | A1 |
20080082153 | Gadsby et al. | Apr 2008 | A1 |
20080097546 | Powers et al. | Apr 2008 | A1 |
20080154110 | Burnes et al. | Jun 2008 | A1 |
20080154178 | Carter et al. | Jun 2008 | A1 |
20080177342 | Snyder | Jul 2008 | A1 |
20080312579 | Chang et al. | Dec 2008 | A1 |
20080312709 | Volpe et al. | Dec 2008 | A1 |
20090005827 | Weintraub et al. | Jan 2009 | A1 |
20090076366 | Palti | Mar 2009 | A1 |
20090210022 | Powers | Aug 2009 | A1 |
20090318988 | Powers | Dec 2009 | A1 |
20090326400 | Huldt | Dec 2009 | A1 |
20100063559 | McIntyre et al. | Mar 2010 | A1 |
20100160712 | Burnett et al. | Jun 2010 | A1 |
20100181069 | Schneider et al. | Jul 2010 | A1 |
20100191141 | Aberg | Jul 2010 | A1 |
20100241181 | Savage et al. | Sep 2010 | A1 |
20100249860 | Shuros et al. | Sep 2010 | A1 |
20110028859 | Chian | Feb 2011 | A1 |
20110071611 | Khuon et al. | Mar 2011 | A1 |
20110208029 | Joucla et al. | Aug 2011 | A1 |
20110237922 | Parker, III et al. | Sep 2011 | A1 |
20110288604 | Kaib et al. | Nov 2011 | A1 |
20110301683 | Axelgaard | Dec 2011 | A1 |
20120101396 | Solosko et al. | Apr 2012 | A1 |
20120112903 | Kaib et al. | May 2012 | A1 |
20120136233 | Yamashita | May 2012 | A1 |
20120158075 | Kaib et al. | Jun 2012 | A1 |
20120158078 | Kaib et al. | Jun 2012 | A1 |
20120203297 | Efimov et al. | Aug 2012 | A1 |
20120259382 | Trier et al. | Oct 2012 | A1 |
20130018251 | Caprio et al. | Jan 2013 | A1 |
20130144365 | Kipke et al. | Jun 2013 | A1 |
20140005736 | Geheb | Jan 2014 | A1 |
20140039593 | Savage et al. | Feb 2014 | A1 |
20140039594 | Savage et al. | Feb 2014 | A1 |
20140221766 | Kinast | Aug 2014 | A1 |
20140276183 | Badower | Sep 2014 | A1 |
20140277226 | Poore et al. | Sep 2014 | A1 |
20140317914 | Shaker | Oct 2014 | A1 |
20140371566 | Raymond et al. | Dec 2014 | A1 |
20140371567 | Raymond et al. | Dec 2014 | A1 |
20140371805 | Raymond et al. | Dec 2014 | A1 |
20140371806 | Raymond et al. | Dec 2014 | A1 |
20150297104 | Chen et al. | Oct 2015 | A1 |
20150327781 | Hernandez-Silveira et al. | Nov 2015 | A1 |
20160206893 | Raymond et al. | Jul 2016 | A1 |
20160213933 | Raymond et al. | Jul 2016 | A1 |
20160213938 | Raymond et al. | Jul 2016 | A1 |
20160296177 | Gray et al. | Oct 2016 | A1 |
20160361533 | Savage et al. | Dec 2016 | A1 |
20160361555 | Savage et al. | Dec 2016 | A1 |
20170252572 | Raymond et al. | Sep 2017 | A1 |
Number | Date | Country |
---|---|---|
10 2006 025864 | Dec 2007 | DE |
1 530 983 | May 2005 | EP |
1 834 622 | Sep 2007 | EP |
2005-144164 | Jun 2005 | JP |
2007-530124 | Nov 2007 | JP |
2008-302254 | Dec 2008 | JP |
2010-511438 | Apr 2010 | JP |
2010-529897 | Sep 2010 | JP |
2012-135457 | Jul 2012 | JP |
2012-529954 | Nov 2012 | JP |
2000-093526 | Jan 2017 | JP |
2011-512227 | Sep 2017 | JP |
2012-501789 | Sep 2017 | JP |
03020362 | Mar 2003 | WO |
WO2010146492 | Dec 2010 | WO |
WO2010151875 | Dec 2010 | WO |
Entry |
---|
PCT International Search Report of PCT/US10/27346; dated Oct. 14, 2010 (4 pgs.). |
PCT Written Opinion of the International Searching Authority of PCT/US10/27346; dated Oct. 14, 2010 (7 pgs.). |
PCT International Preliminary Report on Patentability of PCT/US12/65712; dated Jun. 10, 2014 (6 pgs.). |
PCT International Search Report of PCT/US14/42355; dated Nov. 3, 2010 (2 pgs.). |
PCT Written Opinion of the International Searching Authority of PCT/US14/42355; dated Nov. 3, 2014 (6 pgs.). |
PCT International Search Report of PCT/US14/42356; dated Nov. 3, 2010 (2 pgs.). |
PCT Written Opinion of the International Searching Authority of PCT/US14/42356; dated Nov. 3, 2014 (6 pgs.). |
PCT International Search Report of PCT/US14/42360; dated Nov. 4, 2010 (2 pgs.). |
PCT Written Opinion of the International Searching Authority of PCT/US14/42360; dated Nov. 4, 2014 (4 pgs.). |
PCT International Search Report of PCT/US14/42409; dated Nov. 4, 2010 (2 pgs.). |
PCT Written Opinion of the International Searching Authority of PCT/US14/42409; dated Nov. 4, 2014 (4 pgs.). |
Chinese First Office Action of CN 201080021650.4 (English and Chinese); dated Jul. 24, 2013 (19 pgs.). |
Chinese Second Office Action of CN 201080021650.4 (English and Chinese); dated Jan. 16, 2014 (16 pgs.). |
Chinese Third Office Action of CN 201080021650.4 (English and Chinese); dated Jun. 17, 2014 (18 pgs.). |
Japanese Notification of Reason for Rejection of JP 2012-500855 (English and Japanese); dated Feb. 17, 2014 (3 pgs.). |
PCT International Search Report of PCT/US2012/065712, dated Mar. 29, 2013 (2 pages). |
PCT Written Opinion of PCT/US2012/065712, dated Mar. 29, 2013 (5 pages). |
PCT International Preliminary Report on Patentability and Written Opinion of PCT/EP2007/009879; dated May 19, 2009 (7 pages). |
PCT International Search Report of PCT/EP2007/009879; dated Apr. 29, 2008 (3 pages). |
PCT International Preliminary Report on Patentability of PCT/US2010/027346 dated Sep. 20, 2011 (12 pages). |
Extended European Search Report of EP 2408521 dated Jul. 10, 2012 (8 pages). |
“Changes in the passive electrical properties of human stratum corneum due electroporation” dated Dec. 7, 1994. By U. Pliquett, R. Langer, and J. C. Weaver (11 pages). |
“Electrical properties of the epidermal stratum corneum” dated Aug. 12, 1974. By T. Yamamoto and Y. Yamamoto (8 pages). |
“Non-invasive bioimpedance of intact skin: mathematical modeling and experiments” dated May 2, 2010. By U. Birgersson, E. Birgersson, P. Aberg, I. Nicander, and S. Ollmar (19 pages). |
“Polymer Microneedles for Controlled-Release Drug Delivery” dated Dec. 2, 2005. By J-H. Park, M. G. Allen, and M. R. Prausnitz (12 pages). |
“Utilizing Characteristic Electrical Properties of the Epidermal Skin Layers to Detect Fake Fingers in Biometric Fingerprint Systems—A Pilot Study” dated Dec. 1, 2004. By O. G. Martinsen, S. Clausen, J. B. Nysaether, and S. Grimnes (4 pages). |
“Lack of Pain Associated with Microfabricated Microneedles” dated Oct. 10, 2000. By S. Kaushik, A. H. Hord, D. D. Denson, D. V. McAlliser, S. Smitra, M. G. Allen, and M. R. Prausnitz (3 pages). |
“Two Dimensional Metallic Microelectrode Arrays for Extracellular Stimulation and Recording of Neurons” dated 1993. By A. B. Frazier, D. P. O'Brien, and M. G. Allen (6 pages). |
“Insertion of microneedles into skin: measurement and prediction of insertion force and needle facture force” dated Dec. 10, 2003. By S. P. Davis, B. J. Landis, Z. H. Adams, M. G. Allen, and M. R. Prausnitz (9 pages). |
“Microneedle Insertion Force Reduction Using Vibratory Actuation” dated 2004. By M. Yang and J. D. Zahn (6 pages). |
Yamanouchi, et al., Optimal Small-Capacitor Biphasic Waveform for External Defibrillation; Influence of Phase-1 Tilt and Phase-2 Voltage, Journal of the American Heart Association, vol. 98, pp. 2487-2493 (8 pgs.). |
Number | Date | Country | |
---|---|---|---|
20140371567 A1 | Dec 2014 | US |
Number | Date | Country | |
---|---|---|---|
61835465 | Jun 2013 | US | |
61835478 | Jun 2013 | US |